RFK Jr. Links Tylenol, Circumcision, Autism
Analysis based on 9 articles · First reported Oct 09, 2025 · Last updated Oct 11, 2025
The unproven claims by Robert F. Kennedy Jr. and Donald Trump linking Tylenol to autism could negatively impact public perception and sales of Tylenol, affecting its manufacturer Kenvue. It also creates uncertainty and concern among pregnant women and parents, potentially leading to a decline in acetaminophen use despite medical expert endorsements.
Health Secretary Robert F. Kennedy Jr. made controversial and unproven claims during a Cabinet meeting with President Donald Trump, asserting a link between infant circumcision, the use of Tylenol, and autism. He claimed circumcised boys given Tylenol have double the rate of autism, referencing a 2015 study that showed correlation but not causation and lacked data on painkiller use. Kennedy also reiterated broader discredited theories connecting Tylenol use during pregnancy to autism and suggested those who dismissed his claims were motivated by hatred for Donald Trump. Donald Trump publicly supported these warnings, urging pregnant women and parents not to use Tylenol. Medical experts, including the Society for Maternal-Fetal Medicine and the American College of Obstetricians and Gynecologists, refuted these claims, endorsing acetaminophen as safe for use during pregnancy. Tylenol's manufacturer, Kenvue, also stated there is no causal link between acetaminophen use during pregnancy and fetal developmental issues. Kennedy's remarks have renewed concerns among medical experts about his promotion of scientifically disputed health beliefs.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard